173 related articles for article (PubMed ID: 35877739)
1. Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-
Nagata K; Takatani N; Beppu F; Abe A; Tominaga E; Fukuhara T; Ozeki M; Hosokawa M
Mar Drugs; 2022 Jul; 20(7):. PubMed ID: 35877739
[TBL] [Abstract][Full Text] [Related]
2. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice.
Maeda H; Hosokawa M; Sashima T; Miyashita K
J Agric Food Chem; 2007 Sep; 55(19):7701-6. PubMed ID: 17715888
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-A(y) mice.
Beppu F; Hosokawa M; Niwano Y; Miyashita K
Lipids Health Dis; 2012 Sep; 11():112. PubMed ID: 22962999
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health.
Peng J; Yuan JP; Wu CF; Wang JH
Mar Drugs; 2011; 9(10):1806-1828. PubMed ID: 22072997
[TBL] [Abstract][Full Text] [Related]
5. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice.
Hosokawa M; Miyashita T; Nishikawa S; Emi S; Tsukui T; Beppu F; Okada T; Miyashita K
Arch Biochem Biophys; 2010 Dec; 504(1):17-25. PubMed ID: 20515643
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice.
Beppu F; Hosokawa M; Yim MJ; Shinoda T; Miyashita K
Lipids; 2013 May; 48(5):449-55. PubMed ID: 23516000
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice.
Tsukui T; Konno K; Hosokawa M; Maeda H; Sashima T; Miyashita K
J Agric Food Chem; 2007 Jun; 55(13):5025-9. PubMed ID: 17536824
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
9. Health benefits of fucoxanthin in the prevention of chronic diseases.
Bae M; Kim MB; Park YK; Lee JY
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Nov; 1865(11):158618. PubMed ID: 31931174
[TBL] [Abstract][Full Text] [Related]
10. Identification and tissue distribution of fucoxanthinol and amarouciaxanthin A fatty acid esters in fucoxanthin-fed mice.
Takatani N; Sakimura K; Nagata K; Beppu F; Yamano Y; Maoka T; Hosokawa M
Food Chem; 2023 Jun; 410():135318. PubMed ID: 36608549
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats.
Matsumoto M; Hosokawa M; Matsukawa N; Hagio M; Shinoki A; Nishimukai M; Miyashita K; Yajima T; Hara H
Eur J Nutr; 2010 Jun; 49(4):243-9. PubMed ID: 19888619
[TBL] [Abstract][Full Text] [Related]
13. Identification of Paracentrone in Fucoxanthin-Fed Mice and Anti-Inflammatory Effect against Lipopolysaccharide-Stimulated Macrophages and Adipocytes.
Takatani N; Taya D; Katsuki A; Beppu F; Yamano Y; Wada A; Miyashita K; Hosokawa M
Mol Nutr Food Res; 2021 Jan; 65(2):e2000405. PubMed ID: 33215789
[TBL] [Abstract][Full Text] [Related]
14. Health-Promoting Functions of the Marine Carotenoid Fucoxanthin.
Hosokawa M
Adv Exp Med Biol; 2021; 1261():273-284. PubMed ID: 33783750
[TBL] [Abstract][Full Text] [Related]
15. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice.
Hashimoto T; Ozaki Y; Taminato M; Das SK; Mizuno M; Yoshimura K; Maoka T; Kanazawa K
Br J Nutr; 2009 Jul; 102(2):242-8. PubMed ID: 19173766
[TBL] [Abstract][Full Text] [Related]
16. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
17. Nutraceutical characteristics of the brown seaweed carotenoid fucoxanthin.
Miyashita K; Beppu F; Hosokawa M; Liu X; Wang S
Arch Biochem Biophys; 2020 Jun; 686():108364. PubMed ID: 32315653
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin and lipid metabolism: A minireview.
Muradian Kh; Vaiserman A; Min KJ; Fraifeld VE
Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):891-7. PubMed ID: 26141943
[TBL] [Abstract][Full Text] [Related]
19. Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy.
Méresse S; Fodil M; Fleury F; Chénais B
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291743
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
Martin LJ
Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
